IL6R and rheumatoid arthritis: Mechanistically, YTHDF2 inhibits the excessive proliferation, invasion, and inflammatory factor levels in RA FLS by reducing the mRNA stability of IL‐6R, thereby improving the RA inflammatory response and bone injury.